FUSION ANTIBODIES PLC

Company number NI039740

Date	Type	Description	View / Download
25 Sep 2019	AA	Full accounts made up to 31 March 2019	(62 pages)
25 Sep 2019	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(3 pages)
14 Dec 2018	CS01	Confirmation statement made on 13 December 2018 with updates	(4 pages)
27 Sep 2018	AA	Full accounts made up to 31 March 2018	(56 pages)
26 Sep 2018	RESOLUTIONS	Resolutions RES09 ‐ Resolution of authority to purchase a number of shares RES10 ‐ Resolution of allotment of securities	(3 pages)
05 Jan 2018	AP01	Appointment of Mr Timothy William Watts as a director on 18 December 2017	(2 pages)
20 Dec 2017	SH01	Statement of capital following an allotment of shares on 18 December 2017 GBP 883,647.68	(3 pages)
13 Dec 2017	CS01	Confirmation statement made on 13 December 2017 with updates	(13 pages)
12 Dec 2017	SH01	Statement of capital following an allotment of shares on 11 December 2017 GBP 615,355	(4 pages)
12 Dec 2017	TM01	Termination of appointment of William David John Moore as a director on 11 December 2017	(1 page)
12 Dec 2017	TM01	Termination of appointment of John Ivan George Cadogan as a director on 11 December 2017	(1 page)
11 Dec 2017	CC04	Statement of company's objects	(2 pages)
11 Dec 2017	MAR	Re-registration of Memorandum and Articles	(71 pages)
11 Dec 2017	AUDR	Auditor's report	(2 pages)
11 Dec 2017	AUDS	Auditor's statement	(2 pages)
11 Dec 2017	BS	Balance Sheet	(11 pages)
11 Dec 2017	CERT5	Certificate of re-registration from Private to Public Limited Company	(1 page)
11 Dec 2017	RESOLUTIONS	Resolutions RES02 ‐ Resolution of re-registration	(1 page)
11 Dec 2017	RR01	Re-registration from a private company to a public company	(5 pages)
04 Dec 2017	AA	Full accounts made up to 31 March 2017	(35 pages)
07 Nov 2017	SH02	Sub-division of shares on 25 October 2017	(4 pages)
27 Oct 2017	SH19	Statement of capital on 27 October 2017 GBP 547,655	(3 pages)
27 Oct 2017	SH20	Statement by Directors	(6 pages)
27 Oct 2017	CAP-SS	Solvency Statement dated 25/10/17	(6 pages)
27 Oct 2017	RESOLUTIONS	Resolutions RES13 ‐ Sub-division of shares 25/10/2017 RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES06 ‐ Resolution of reduction in issued share capital	(2 pages)